Equities analysts forecast that Clorox Co (NYSE:CLX) will report earnings per share (EPS) of $1.31 for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Clorox’s earnings. The highest EPS estimate is $1.35 and the lowest is $1.25. Clorox posted earnings of $1.40 per share during the same quarter last year, which indicates a negative year-over-year growth rate of 6.4%. The firm is scheduled to announce its next earnings report on Monday, February 3rd.

According to Zacks, analysts expect that Clorox will report full-year earnings of $6.16 per share for the current fiscal year, with EPS estimates ranging from $6.07 to $6.21. For the next year, analysts anticipate that the firm will post earnings of $6.41 per share, with EPS estimates ranging from $6.27 to $6.47. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that that provide coverage for Clorox.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, October 31st. The company reported $1.59 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.54 by $0.05. Clorox had a net margin of 13.20% and a return on equity of 123.56%. The firm had revenue of $1.51 billion for the quarter, compared to the consensus estimate of $1.51 billion. During the same quarter in the previous year, the company earned $1.62 EPS. The company’s revenue for the quarter was down 3.6% on a year-over-year basis.

A number of research analysts recently issued reports on the stock. Bank of America dropped their target price on shares of Clorox from $165.00 to $160.00 and set a “neutral” rating on the stock in a research report on Thursday, October 3rd. UBS Group dropped their target price on shares of Clorox from $128.00 to $125.00 and set a “sell” rating on the stock in a research report on Thursday, October 3rd. Credit Suisse Group dropped their target price on shares of Clorox from $172.00 to $168.00 and set an “outperform” rating on the stock in a research report on Thursday, October 3rd. Citigroup dropped their target price on shares of Clorox from $167.00 to $163.00 and set a “neutral” rating on the stock in a research report on Thursday, October 3rd. Finally, Deutsche Bank dropped their target price on shares of Clorox from $151.00 to $145.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Five investment analysts have rated the stock with a sell rating, eight have issued a hold rating and two have issued a buy rating to the company. Clorox presently has a consensus rating of “Hold” and an average price target of $152.00.

In other Clorox news, SVP Andrew J. Mowery sold 5,648 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $146.29, for a total transaction of $826,245.92. Following the completion of the sale, the senior vice president now owns 15,920 shares in the company, valued at approximately $2,328,936.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Denise Garner sold 725 shares of the business’s stock in a transaction on Friday, November 22nd. The shares were sold at an average price of $146.34, for a total transaction of $106,096.50. Following the sale, the senior vice president now owns 5,805 shares of the company’s stock, valued at approximately $849,503.70. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Hedge funds have recently made changes to their positions in the business. Asahi Life Asset Management CO. LTD. bought a new stake in shares of Clorox in the 2nd quarter worth $340,000. Cambridge Investment Research Advisors Inc. grew its stake in shares of Clorox by 3.2% in the 2nd quarter. Cambridge Investment Research Advisors Inc. now owns 27,406 shares of the company’s stock worth $4,196,000 after acquiring an additional 858 shares in the last quarter. Ontario Teachers Pension Plan Board grew its stake in shares of Clorox by 209.0% in the 2nd quarter. Ontario Teachers Pension Plan Board now owns 37,846 shares of the company’s stock worth $5,795,000 after acquiring an additional 25,599 shares in the last quarter. CWM LLC grew its stake in shares of Clorox by 75.6% in the 2nd quarter. CWM LLC now owns 92,127 shares of the company’s stock worth $14,106,000 after acquiring an additional 39,668 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in shares of Clorox by 4.2% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 969,843 shares of the company’s stock worth $148,493,000 after acquiring an additional 39,390 shares in the last quarter. Institutional investors and hedge funds own 77.67% of the company’s stock.

Shares of Clorox stock traded down $0.29 during trading on Friday, reaching $152.46. 1,031,758 shares of the company traded hands, compared to its average volume of 789,893. The company has a debt-to-equity ratio of 4.69, a current ratio of 0.87 and a quick ratio of 0.52. Clorox has a 1-year low of $143.58 and a 1-year high of $167.54. The company has a 50 day moving average price of $148.25 and a 200-day moving average price of $153.89. The firm has a market capitalization of $19.06 billion, a PE ratio of 24.12, a P/E/G ratio of 4.85 and a beta of 0.38.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.06 per share. The ex-dividend date is Tuesday, January 28th. This represents a $4.24 dividend on an annualized basis and a yield of 2.78%. Clorox’s dividend payout ratio (DPR) is presently 67.09%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Market Timing

Get a free copy of the Zacks research report on Clorox (CLX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.